Radiological progression in early rheumatoid arthritis after DMARDS: A one-year follow-up study in a clinical setting

Rheumatology

Volumn 42, Issue 9, 2003, Pages 1044-1049

  Sanmarti, R ^a   Gomez, A ^a   Ercilla, G ^a   Gratacos, J ^b   Larrosa, M ^a   Suris, X ^c   Vinas O ^a   Salvador, G ^a   Munoz Gomez J ^a   Canete J D ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL DE SABADELL   (Spain)

^c HOSPITAL GENERAL DE GRANOLLERS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; AUROTHIOMALATE; EPITOPE; GOLD SALT; INDOMETACIN; METHOTREXATE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; TRIAMCINOLONE ACETONIDE; TRIAMCINOLONE HEXACETONIDE;

ADULT; AGED; ARTICLE; BONE EROSION; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DRUG RESPONSE; ETHNOLOGY; FEMALE; FOLLOW UP; FOOT RADIOGRAPHY; FREQUENCY ANALYSIS; GENDER; HAND RADIOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOGENETICS; JOINT INJURY; JOINT RADIOGRAPHY; LABORATORY TEST; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PAIN ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SKIN DISEASE; SPAIN; VISUAL ANALOG SCALE;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0141839019     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keg284     Document Type: Article

References (39)

1. Scott DL. Prognostic factors in early rheumatoid arthritis. Rheumatology 2000;39(Suppl. 1):24-9.
2. van der Heijde DMFM. Radiographic imaging: the gold standard for assessment of disease progression in rheumatoid arthritis. Rheumatol 2000;39(Suppl. 1):9-16.
3. van der Heijde DM. Joint erosions and patients with early rheumatoid arthritis. Br J Rheumatol 1995;34(Suppl. 2):74-8.
4. Fuchs HA, Kaye J, Callahan LF, Nance EPJ, Pincus T. Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease. J Rheumatol 1989;16:585-91.
5. Wolfe F, Sharp JT. Radiographic outcome of recent-onset RA. A 19-year study of radiographic progression. Arthritis Rheum 1998;41:1571-82.
6. Jansen LMA, van der Horst-Bruinsma IE, van Schaardenburg D, Bezemer PD, Dijkmans BAC. Predictors of radiographic joint damage in patients with early rheumatoid arthritis. Ann Rheum Dis 2001;60:924-7.
7. Corbett M, Dalton S, Young A, Silman A, Shipley M. Factors predicting death, survival and functional outcome in a prospective study of early rheumatoid disease over fifteen years. Ann Rheum Dis 1993;32:717-23.
8. Brennan P, Harrison B, Barrett E et al. A simple algorithm to predict the development of radiological erosions in patients with early rheumatoid arthritis: prospective cohort study. Br Med J 1996;24:471-6.
9. Combe B, Dougados M, Goupille P et al. Prognostic factors for radiographic damage in early rheumatoid arthritis. A multiparameter prospective study. Arthritis Rheum 2001;44:1736-43.
10. van der Heide A, Remme CA, Hofman DM, Jacobs JWG, Bijlsma JWJ. Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis. Arthritis Rheum 1995;38:1466-74.
11. Eberhardt K, Fex E, Johnson U, Wollheim FA. Associations of HLA-DRB and -DQB genes with two and five year outcome in rheumatoid arthritis. Ann Rheum Dis 1996;55:34-9.
12. van Zeben D, Hazes JMW, Zwinderman AH, Vanderbroucke JP, Breedveld FC. Factors predicting outcome of rheumatoid arthritis: results of a follow-up study. J Rheumatol 1993;20:1288-96.
13. Drosos AA, Lanchbury JS, Panayi GS, Moutsopoulos HM. Rheumatoid arthritis in Greek and British patients. A comparative clinical, radiologic, and serologic study. Arthritis Rheum 1992;35:745-8.
14. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
15. Gómez A, Viñas O, Sanmarti R, Salvador G, Cañete JD, Muñoz-Gómez J. ¿Es posible mejorar la sensibilidad diagnóstica de los AKA en la artritis reumatoide? Rev Esp Reumatol 1999;26:159.
16. Bizzaro N, Mazzanti G, Tonutti E, Villalta D, Tozzoli R. Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem 2001;47:1089-93.
17. Pincus T, Summey JA, Soraci SA, Hummon NP, Wallston KA. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 1983;26:1346-53.
18. Kirwan JR. Using the Larsen index to assess radiographic progression in rheumatoid arthritis. J Rheumatol 2000; 27:264-8.
19. Bruynesteyn K, van der Heijde D, Boers M et al. Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts. J Rheumatol 2001;28:904-10.
20. Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. Control Clin Trials, 1991; 12(Suppl. 4):142-58.
21. Mottönen TT. Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis. Ann Rheum Dis 1988;34:815-21.
22. Paimela L, Heiskanen A, Kurki P, Helve T, Leirisalo-Repo M. Serum hyaluronate levels as a predictor of radiological progression in early rheumatoid arthritis. Arthritis Rheum 1991;34:815-21.
23. Higami K, Hakoda M, Matsuda Y et al. Lack of association of HLADRB1 genotype with radiological progression in Japanese patients with early rheumatoid arthritis. Arthritis Rheum 1997;40:2241-7.
24. Richi P, Balsa A, Muñoz-Fernandez S et al. Factors related to radiological damage in 61 Spaniards with early rheumatoid arthritis. Ann Rheum Dis 2002;61:270-2.
25. van der Horst-Bruinsma IE, Speyer I, Visser H, Breedveld FC, Hazes JM. Diagnosis and course of early-onset arthritis: results of a special early arthritis clinic to routine patient care. Br J Rheumatol 1998;37:1084-8.
26. Gough A, Faint J, Salmon M et al. Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome. Arthritis Rheum 1994; 8:1166-70.
27. Weyand CM, Hicock KC, Conn DL, Goronzy JJ. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 1992;117:801-6.
28. Belghomari H, Saraux A, Allain J, Guedes C, Youinou P, Le Goff P. Risk factors for radiographic articular destruction of hands and wrists in rheumatoid arthritis. J Rheumatol 1999;26:2534-8.
29. Mattey DL, Hassell AB, Dawes PT et al. Independent association of rheumatoid factor and the HLA-DRB1 shared epitope with radiographic outcome in rheumatoid arthritis. Arthritis Rheum 2001;44:1529-33.
30. Lard LR, Boers M, Verhoeven A et al. Early and aggressive treatment of rheumatoid arthritis patients affects the association of HLA class II antigens with progression of joint damage. Arthritis Rheum 2002; 46:899-905.
31. Mottonen T, Paimela L, Leirisalo-Repo M, Kautiainen H, Ilonen J, Hannonen P. Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with 'sawtooth' strategy. Ann Rheum Dis 1998;57:533-9.
32. Kroot E-JAA, de Jong BAW, van Leeuwen MA et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 2000;43:1831-5.
33. Rau R, Herborn G, Menninger H, Sangha O. Progression in early rheumatoid arthritis: 12 month results from a randomized controlled trial comparing methotrexate and gold sodium thiomalate. Br J Rheumatol 1998;37:1220-6.
34. Rau R, Herborn HG, Menninger H, Sangha O. Radiographic outcome after three years of patients with early erosive rheumatoid arthritis treated with intramuscular methotrexate or parenteral gold. Extension of a one-year double-blind study in 174 patients. Rheumatology 2002; 41:196-204.
35. Kirwan JR. Systemic low-dose glucocorticoid treatment in rheumatoid arthritis. Rheum Dis Clin North Am 2001; 27:389-403.
36. van Leeuwen MA, van Rijswijk MH, van del Heijde DMFM et al. The acute phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease. Br J Rheumatol 1993;32(Suppl. 3):9-13.
37. van Leewen MA, van Rijswijk MH, Sluiter WJ et al. Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system. J Rheumatol 1997;24:20-7.
38. Coste J, Spira A, Clerc D, Paolaggi JB. Prediction of articular destruction in rheumatoid arthritis: disease activity markers revisited. J Rheumatol 1997;24:28-34.
39. Bukhari M, Harrison B, Lunt M, Scott DG, Symmons DP, Silman AJ. Time to first occurrence of erosions in inflammatory polyarthritis: results from a prospective community-based study. Arthritis Rheum 2001;44:1231-3.